VEEV
Veeva Systems Inc
$184.22
+6.75 (+3.80%)
Institutional flow:
-100% holders QoQ
Insider flow:
Net -$231.9K over 90 days · 100% sells
Institution breadth:
2 holders — near 3-yr low, contrarian setup
4 Up Days
Indicators
Price
Panels
Event markers
Price & Indicators
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$184.22
Open$182.00
Day$181.05–189.12
52W$148.05–310.50
Avg vol 30d2.7M
Short int7.5M · 2.6d
Short vol70%
Last earningsJun 3, 2026
DataJan 2020–Jul 2026
Filing10-Q · Jun 5
Equibles Rating
blended score
Overall
Buy
Technical · trend & momentum
Buy
+
Price vs 50-day avg · +12% above
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−14% below
+
Price vs 50-day avg
+12% above
◦
RSI (14)
66 · neutral
+
MACD trend
positive
◦
52-week position
22% · mid-range
Sentiment · smart money
Bearish
−
Institutional flow · -100% holders QoQ
◦
Trend (MA cross)
50d $165 › 200d $214 — 200d above 50d
−
Institutional flow
-100% holders QoQ
−
Insider flow
Net -$231.9K over 90 days · 100% sells
+
Short interest
4.62% of float · ▼ -14.7% MoM · 2.6 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
2 holders — near 3-yr low, contrarian setup
Fundamentals
Excellent
+
Revenue growth · +28% Y/Y
+
Revenue growth
+28% Y/Y
+
Gross margin
219%, contracting
+
EPS growth
+26% Y/Y
+
Free cash flow
$1.4B
+
Buyback
$1.6B remaining
+
Balance sheet
net cash $1.4B
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Key facts
Market Cap
$29.93B
Shares
162,443,291
CIK
1393052
CUSIP
922475108
13F Activity (30d)
39 filings
6 filers
Website
Visit website
Investor Relations
Investor relations
Up next
Next earnings call
Sep 2, 2026
Est · unconfirmed
· in 9 wks
FQ2-27 quarter ends
~Jul 31, 2026
Est
filed Jun 5, 2026
Guidance & track record
Latest guidance
· from the 8-K filed Jun 3, 2026
fiscal second quarter ending July 31, 2026
Total revenues
$902M – $905M
prior qtr $882.95M
midpoint +2.3% QoQ
Non-GAAP operating income
Non-GAAP
$392M – $395M
Non-GAAP fully diluted net income per share
Non-GAAP
$2.21 – $2.22
fiscal year ending January 31, 2027
Total revenues
$3.64B – $3.65B
prior FY $3.2B
midpoint +13.9% Y/Y
Non-GAAP operating income
Non-GAAP
$1.61B
Non-GAAP fully diluted net income per share
Non-GAAP
$9.05
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−14% below
Bearish
Price vs 50-day avg
+12% above
Bullish
RSI (14)
66 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
22% · mid-range
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $165 › 200d $214 — 200d above 50d
Institutional flow
Distributing
-100% holders QoQ
Insider flow
Distributing
Net -$231.9K over 90 days · 100% sells
Short interest
Falling
4.62% of float · ▼ -14.7% MoM · 2.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
2 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $148
Now $184 · 22%
52-wk high $311
vs 200-day avg -14%
vs 50-day avg +12%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases| Metric | Latest | Period | YoY |
|---|---|---|---|
| Non-GAAP fully diluted net income per share non-GAAP | $2.24 | Q1 FY2027 | — |
| Non-GAAP net income non-GAAP | $371.1M | Q1 FY2027 | — |
| Non-GAAP operating income non-GAAP | $395.4M | Q1 FY2027 | — |
Figures exactly as the company stated them · period links open the stating release · YoY needs the prior-year figure on file
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VEEV
this stock
Veeva Systems Inc
|
$29.93B | -17.5% | +28.1% | — | 4.6% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$15.15B | -12.5% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$13.52B | +86.2% | -0.4% | — | 4.8% |
|
TEM
Tempus AI, Inc.
|
$10.47B | -1.3% | +65.8% | — | 21.2% |
|
HNGE
Hinge Health, Inc.
|
$9.32B | +83.1% | +50.6% | — | 7.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VEEV | +14.2% | +0.7% | -23.0% | +3.8% | -17.5% |
| SPY | +1.7% | -1.8% | +8.2% | -0.1% | +9.4% |
| vs SPY | +12.5% | +2.5% | -31.2% | +3.9% | -26.8% |
Capital returns
Buyback program
· as of Apr 30, 2026
Authorized
$2.00B
Spent (derived)
$400.00M
Remaining
$1.60B
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.